On CNBC’s “Halftime Report Final Trades” on Tuesday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he is staying long on AbbVie Inc. (NYSE:ABBV).
Supporting his view, Guggenheim analyst Vamil Divan maintained an AbbVie Buy rating on Oct. 20, raising the price target from $227 to $242.
Jim Lebenthal, partner at Cerity Partners, picked QUALCOMM Incorporated (NASDAQ:QCOM) as his final trade.
According to recent news, Satellite communications company Iridium Communications (NASDAQ:IRDM) …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades” on Tuesday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he is staying long on AbbVie Inc. (NYSE:ABBV).
Supporting his view, Guggenheim analyst Vamil Divan maintained an AbbVie Buy rating on Oct. 20, raising the price target from $227 to $242.
Jim Lebenthal, partner at Cerity Partners, picked QUALCOMM Incorporated (NASDAQ:QCOM) as his final trade.
According to recent news, Satellite communications company Iridium Communications (NASDAQ:IRDM) …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades” on Tuesday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he is staying long on AbbVie Inc. (NYSE:ABBV).
Supporting his view, Guggenheim analyst Vamil Divan maintained an AbbVie Buy rating on Oct. 20, raising the price target from $227 to $242.
Jim Lebenthal, partner at Cerity Partners, picked QUALCOMM Incorporated (NASDAQ:QCOM) as his final trade.
According to recent news, Satellite communications company Iridium Communications (NASDAQ:IRDM) …Full story available on Benzinga.com Read MoreABBV, APTV, CNBC, Halftime Report Final Trades, IRDM, Jason Snipe, Jim Lebenthal, Joe Terranova, Long Ideas, News, PANW, QCOM, Stephanie Link, Markets, Media, Trading Ideas, QCOM, US7475251036, IRDM, US46269C1027, PANW, ABBV, APTV, Long Ideas, News, Markets, Media, Trading Ideas, Benzinga Markets
